# Confocal Laser Endomicroscopy: Real-Time Histology at the Fingertips: A Comprehensive Review of Current Applications of Endomicroscopy in Barrett Esophagus, Inflammatory Bowel Disease, and Colorectal Lesions

**Authors:** Eyad Gadour, Bogdan Miutescu, Abed Al-Lehibi, Mustafa Mohamed, Emad Aljahdli, Mohammed Albeshir, Alexandru Popa, Bodour Raheem, Antonio Facciorusso

PMC · DOI: 10.3390/medicina62020415 · 2026-02-22

## TL;DR

Confocal laser endomicroscopy allows real-time tissue analysis during endoscopy, offering faster diagnosis for conditions like Barrett's esophagus and colorectal lesions.

## Contribution

This paper reviews the current diagnostic and clinical applications of confocal laser endomicroscopy in gastroenterology and related fields.

## Key findings

- CLE provides diagnostic accuracy comparable to histology for Barrett’s esophagus and colorectal lesions.
- CLE reduces diagnostic delays by enabling real-time in vivo optical biopsies.
- Despite its promise, CLE is used as a complementary tool rather than a replacement for traditional histopathology.

## Abstract

Confocal laser endomicroscopy (CLE) is an innovative diagnostic modality that facilitates real-time in vivo optical biopsies of various tissues within luminal and ductal structures. Since its introduction in 2004, the application of this tool has broadened from diagnostic purposes to encompass management and prognostic evaluation in fields such as gastroenterology, neurosurgery, urology, and dermatology. This comprehensive review examines the current applications of endomicroscopy in Barrett’s esophagus (BE), inflammatory bowel disease (IBD), and colorectal lesions. Evidence from the literature suggests that CLE offers a potential solution to the diagnostic limitations associated with white-light endoscopy and histology. With a diagnostic accuracy nearly equivalent to that of histology, CLE is emerging as a promising tool to mitigate the delays related to awaiting histology results for clinical and therapeutic decision-making. However, its use is mainly as a complementary diagnostic method rather than an alternative to histopathology or other ancillary studies. Nevertheless, its widespread adoption remains limited, and further research is necessary to ascertain its overall benefits and cost implications of integrating it into patient care.

## Linked entities

- **Diseases:** Barrett’s esophagus (MONDO:0013662), inflammatory bowel disease (MONDO:0005265)

## Full-text entities

- **Genes:** RTRAF (RNA transcription, translation and transport factor) [NCBI Gene 51637] {aka C14orf166, CGI-99, CGI99, CLE, CLE7, LCRP369}, mucin [NCBI Gene 100508689]
- **Diseases:** biliary strictures (MESH:D003251), hypotension (MESH:D007022), metaplasia (MESH:D008679), colorectal adenocarcinoma (MESH:D003110), gastric intestinal metaplasia (MESH:D013274), sessile serrated lesions (MESH:D009059), rash (MESH:D005076), Colorectal polyps (MESH:D003111), Behcet's disease (MESH:D001528), Adenoma dysplasia (MESH:D000236), EMR scars (MESH:D002921), Cancer (MESH:D009369), adenocarcinoma (MESH:D000230), intraepithelial neoplasia (MESH:D002578), abdominal pain (MESH:D015746), pancreatic cystic conditions (MESH:D003550), BE (MESH:D001471), Inflammation (MESH:D007249), atrophic gastritis lesions (MESH:D005757), GERD (MESH:D005764), injury to (MESH:D014947), Chron's disease (MESH:D004194), Dysplasia (MESH:D015792), GEJ (MESH:D008309), Helicobacter pylori (MESH:D016481), epigastric pain (MESH:D010146), hiatal hernias (MESH:D006551), Intestinal metaplasia (MESH:D007410), fistulas (MESH:D005402), erythema (MESH:D004890), gastritis (MESH:D005756), primary sclerosing cholangitis (MESH:D015209), infectious colitis (MESH:D003141), UC (MESH:D003093), IBD (MESH:D015212), hyperplastic polyps (MESH:D011127), thrombocytosis (MESH:D013922), nausea and vomiting (MESH:D020250), phlegmon (MESH:D002481), granuloma (MESH:D006099), intestinal tuberculosis (MESH:D014376), Goblet (MESH:D002276), GIT (MESH:D005770), peritoneal metastasis of (MESH:D010538), GI diseases (MESH:D005767), CD (MESH:D003424), ulcerative disease (MESH:D014456), adenomatous (MESH:D011125), epithelial neoplasia (MESH:D009375), anemia (MESH:D000740), adenomatous polyps (MESH:D018256), CRC (MESH:D015179), intra-abdominal abscesses (MESH:D018784)
- **Chemicals:** Cresyl violet (MESH:C028911), propofol (MESH:D015742), Acriflavine (MESH:D000167), fentanyl (MESH:D005283), pafolacianine (MESH:C000720187), midazolam (MESH:D008874), eosin (MESH:D004801), Fluorescein (MESH:D019793), AQ-Flex 19 (-), hematoxylin (MESH:D006416)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12943492